Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of Novel Pyrazole Analogues of Curcumin

被引:3
作者
Kumar, Dileep [1 ]
Harish, B. G. [2 ]
Gangwar, Mayank [3 ,4 ]
Kumar, Manish [1 ]
Kumar, Dharmendra
Tilak, Ragini
Nath, Gopal
Kumar, Ashok [1 ]
Singh, Sushil Kumar [1 ]
机构
[1] Indian Inst Technol, BHU, Dept Pharmaceut, Pharmaceut Chem Res Lab, Varanasi 221005, Uttar Pradesh, India
[2] MS Ramaiah Inst Technol, Dept Biotechnol, Bengaluru, Karnataka, India
[3] Inst Med Sci, BHU, Dept Pharmacol, Varanasi 221005, Uttar Pradesh, India
[4] Inst Med Sci, BHU, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India
关键词
Autodock; 4.2; Active sites; Antimicrobial activity; GlcN-6-P synthase; Pyrazole; In silico; SELECTIVE SERIES; DISCOVERY; DERIVATIVES; INHIBITORS; POTENT;
D O I
10.2174/15701808113106660087
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of pyrazole analogues of curcumin were synthesized and investigated for in vitro and in silico antimicrobial activity. The structures of newly synthesized compounds were ascertained on the basis of their analytical and spectral profiles. The compounds were subjected to molecular docking studies for the inhibition of the enzyme glucosamine-6-phosphate synthase [GlcN-6-P]. The autodock program 4.2 was employed to perform automated molecular docking. The docking study was performed on two different active sites of the enzyme reside with the amino acid series Cys1, Arg73, Thr76, His77, Asn98, Gly99, Ile100 and Gly301, Thr302, Ser303, Ser347, Gln348, Ser349, Thr352, Lys485, Ala602, Val605 respectively. Among the thirteen molecules taken for docking studies, compounds cp10, cp11 and cp12 showed minimum docking energy and inhibition constant and may be considered as good inhibitor of GlcN-6-P synthase.
引用
收藏
页码:474 / 483
页数:10
相关论文
共 29 条
[1]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[2]   Synthesis and biological evaluation of new curcumin derivatives as antioxidant and antitumor agents [J].
Bayomi, Said M. ;
El-Kashef, Hassan A. ;
El-Ashmawy, Mahmoud B. ;
Nasr, Magda N. A. ;
El-Sherbeny, Magda A. ;
Badria, Farid A. ;
Abou-Zeid, Laila A. ;
Ghaly, Mariam A. ;
Abdel-Aziz, Naglaa I. .
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (03) :1147-1162
[3]   Synthesis, characterization, DNA cleavage and in vitro antimicrobial activities of copper(II) complexes of Schiff bases containing a 2,4-disubstituted thiazole [J].
Bharti, Sanjay K. ;
Patel, Saurabh K. ;
Nath, Gopal ;
Tilak, Ragini ;
Singh, Sushil K. .
TRANSITION METAL CHEMISTRY, 2010, 35 (08) :917-925
[4]   CASTp: Computed atlas of surface topography of proteins [J].
Binkowski, TA ;
Naghibzadeh, S ;
Liang, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3352-3355
[5]   Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models [J].
Bonnefous, Celine ;
Payne, Joseph E. ;
Roppe, Jeffrey ;
Zhuang, Hui ;
Chen, Xiaohong ;
Symons, Kent T. ;
Nguyen, Phan M. ;
Sablad, Marciano ;
Rozenkrants, Natasha ;
Zhang, Yan ;
Wang, Li ;
Severance, Daniel ;
Walsh, John P. ;
Yazdani, Nahid ;
Shiau, Andrew K. ;
Noble, Stewart A. ;
Rix, Peter ;
Rao, Tadimeti S. ;
Hassig, Christian A. ;
Smith, Nicholas D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) :3047-3062
[6]   A new generation of specific Tryponosoma cruzi trans-sialidase inhibitors [J].
Buchini, Sabrina ;
Buschiazzo, Alejandro ;
Withers, Stephen G. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (14) :2700-2703
[7]   Discovery of a potent and selective series of pyrazole bacterial methionyl-tRNA synthetase inhibitors [J].
Finn, J ;
Mattia, K ;
Morytko, M ;
Ram, S ;
Yang, YF ;
Wu, XM ;
Mak, E ;
Gallant, P ;
Keith, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) :2231-2234
[8]   ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY - A RAPID ACCESS TO ATOMIC CHARGES [J].
GASTEIGER, J ;
MARSILI, M .
TETRAHEDRON, 1980, 36 (22) :3219-3228
[9]   The effect of halogenation on blood-brain barrier permeability of a novel peptide drug [J].
Gentry, CL ;
Egleton, RD ;
Gillespie, T ;
Abbruscato, TJ ;
Bechowski, HB ;
Hruby, VJ ;
Davis, TP .
PEPTIDES, 1999, 20 (10) :1229-1238
[10]   ATOMIC PHYSICOCHEMICAL PARAMETERS FOR 3-DIMENSIONAL-STRUCTURE-DIRECTED QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS .2. MODELING DISPERSIVE AND HYDROPHOBIC INTERACTIONS [J].
GHOSE, AK ;
CRIPPEN, GM .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1987, 27 (01) :21-35